ISOLUTE® C8 is a medium retentive, non-polar sorbent for extraction of a range of analytes from aqueous samples using a non-polar retention mechanism
ISOLUTE® C8 is the most commonly used C8 sorbent for the extraction of acidic, neutral and basic compounds from aqueous sample matrices. The sorbent is not end-capped, and secondary silanol interactions can be exploited to enhance extract purity and method robustness for basic analytes.
ISOLUTE C8 is available in a wide range of SPE columns and 96-well plate formats.
ISOLUTE C8 is also available as loose sorbent (100g pack).
Part No. | Description | Pack Size | List Price | |
---|---|---|---|---|
290-0100-B | ISOLUTE® C8 1 g/3 mL | 50 | 248 USD | Add to quote/cart |
290-0100-C | ISOLUTE® C8 1 g/6 mL | 30 | 157 USD | Add to quote/cart |
290-0010-A | ISOLUTE® C8 100 mg/1 mL | 100 | 212 USD | Add to quote/cart |
290-0010-B | ISOLUTE® C8 100 mg/3 mL | 50 | 121 USD | Add to quote/cart |
290-0010-BA | ISOLUTE® C8 100 mg/3 mL (ASPEC Adaptor) | 50 | 163 USD | Add to quote/cart |
290-0010-C | ISOLUTE® C8 100 mg/6 mL | 30 | 108 USD | Add to quote/cart |
290-0200-CG | ISOLUTE® C8 2 g/6 mL (Tabless) | 30 | 252 USD | Add to quote/cart |
290-0200-CGA | ISOLUTE® C8 2 g/6 mL (Tabless) (ASPEC Adaptor) | 30 | 301 USD | Add to quote/cart |
290-0020-H | ISOLUTE® C8 200 mg/10 mL (3 mL XL) | 50 | 148 USD | Add to quote/cart |
290-0020-B | ISOLUTE® C8 200 mg/3 mL | 50 | 142 USD | Add to quote/cart |
290-0020-C | ISOLUTE® C8 200 mg/6 mL | 30 | 108 USD | Add to quote/cart |
290-0002-A | ISOLUTE® C8 25 mg/1 mL | 100 | 204 USD | Add to quote/cart |
290-0005-A | ISOLUTE® C8 50 mg/1 mL | 100 | 204 USD | Add to quote/cart |
290-0050-B | ISOLUTE® C8 500 mg/3 mL | 50 | 163 USD | Add to quote/cart |
9290-0100 | ISOLUTE® C8 Bulk 100 g | 1 | 331 USD | Add to quote/cart |
290-0025-P01 | ISOLUTE®-96 C8 25 mg Fixed Well Plate | 1 | 340 USD | Add to quote/cart |
290-0050-P01 | ISOLUTE®-96 C8 50 mg Fixed Well Plate | 1 | 346 USD | Add to quote/cart |
Biotage is the Global Go-To Separations Company, supporting customers from drug discovery and development through to diagnostics and analytical testing with intelligent and sustainable workflow solutions. Our expertise and top-tier separation solutions play a key role in streamlining our customers’ workflows and improving their outcomes. Headquartered in Sweden, Biotage operates globally with 700 employees, serving over 80 countries. Our company is listed on NASDAQ Stockholm (BIOT).
Copyright © 2024 Biotage